Try it
Pharmacology · Chemotherapy: secukinumab cautions
Sample itemA patient with moderate plaque psoriasis is to start secukinumab, an IL-17A antibody. Which pre-existing condition calls for particular caution because it may worsen on this drug?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Crohn disease
IL-17 inhibitors can exacerbate or unmask inflammatory bowel disease, and they also increase mucocutaneous candidiasis. Ankylosing spondylitis and psoriatic arthritis are approved indications for secukinumab, and gout is not worsened by it.
Option by option
A. Gout
Gout is not made worse by IL-17 blockade.
B. Ankylosing spondylitis
Ankylosing spondylitis is an approved indication for secukinumab.
C. Crohn disease (correct)
Correct. IL-17 blockade can worsen Crohn disease.
D. Psoriatic arthritis
Psoriatic arthritis is an approved indication for secukinumab.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?